Gotowa bibliografia na temat „Os – Infections – Thérapeutique”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Os – Infections – Thérapeutique”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Os – Infections – Thérapeutique"
Batard, Eric, i Gilles Potel. "Thérapeutique des infections à staphylocoques". EMC - Maladies infectieuses 3, nr 4 (styczeń 2006): 1–8. http://dx.doi.org/10.1016/s1166-8598(06)41682-3.
Pełny tekst źródłaMootien, J. Y., i J. R. Zahar. "Entérobactéries productrices de carbapénémases en médecine intensive : thérapeutique". Médecine Intensive Réanimation 27, nr 4 (lipiec 2018): 372–80. http://dx.doi.org/10.3166/rea-2018-0058.
Pełny tekst źródłaValade, S., E. Canet i E. Mariotte. "Syndrome d’activation macrophagique d’origine infectieuse : le point de vue du réanimateur". Médecine Intensive Réanimation 27, nr 3 (maj 2018): 239–48. http://dx.doi.org/10.3166/rea-2018-0048.
Pełny tekst źródłaChanal, Johan, François Lassau, Philippe Morand, Michel Janier i Nicolas Dupin. "Actualités diagnostique et thérapeutique des infections à Neisseria gonorrhoeae". La Presse Médicale 42, nr 4 (kwiecień 2013): 454–58. http://dx.doi.org/10.1016/j.lpm.2012.09.023.
Pełny tekst źródłaCastelain, V., G. Morel, M. P. Ledoux i R. Herbrecht. "Prise en charge des infections invasives à champignons filamenteux en réanimation : quel(s) antifongique(s) utiliser ?" Médecine Intensive Réanimation 29, nr 1 (1.03.2020): 24–31. http://dx.doi.org/10.37051/mir-00005.
Pełny tekst źródłaGerber, V., B. Dimitrov, V. Greigert, M. Mohseni, G. M. Pelami, P. David, P. Keller i M. Martinot. "Analyse clinique, microbiologique et thérapeutique des infections de prothèse abdominale". Médecine et Maladies Infectieuses 48, nr 4 (czerwiec 2018): S84—S85. http://dx.doi.org/10.1016/j.medmal.2018.04.211.
Pełny tekst źródłaHarf-Monteil, C., J. Gaudias, J. Loichot i H. Monteil. "Infections de plaies à Aeromonas : un piège diagnostique et thérapeutique". Médecine et Maladies Infectieuses 33, nr 11 (listopad 2003): 590–92. http://dx.doi.org/10.1016/s0399-077x(03)00003-9.
Pełny tekst źródłaMongardon, N., i A. Cariou. "Hypothermie thérapeutique après arrêt cardiaque et infections acquises en réanimation". Réanimation 24, nr 3 (23.03.2015): 224–35. http://dx.doi.org/10.1007/s13546-015-1045-7.
Pełny tekst źródłaKERDOUN, Mohamed Amine, Hadjer BALLOUTI, Yasmine GUERGOUR, Hanane GUELALTA, Assia YAMOUN, Sabah BENBOUDIAF i Faiza BOUCHALA. "Demonstration of inter and intraindividual pharmacokinetic variability during gentamicin treatment in hospitals". Batna Journal of Medical Sciences (BJMS) 5, nr 1 (25.12.2018): 53–56. http://dx.doi.org/10.48087/bjmsoa.2018.5113.
Pełny tekst źródłaBARRÉ, M., J. MORIN, A. VALOIS, H. LEHOT, J. E. BLATTEAU i J. J. MORAND. "Mise au point sur l’utilisation de l’oxygénothérapie hyperbare en dermatologie". Médecine et Armées Vol.49 No.4, Volume 49, Numéro 4 (20.12.2023): 99–112. http://dx.doi.org/10.17184/eac.8054.
Pełny tekst źródłaRozprawy doktorskie na temat "Os – Infections – Thérapeutique"
Nivoix, Yasmine. "Infections fongiques invasives : épidémiologie et optimisation thérapeutique". Strasbourg, 2009. http://www.theses.fr/2009STRA2006.
Pełny tekst źródłaNahum, Joseph. "Thérapeutique des infections à Herpes simplex virus". Paris 5, 1999. http://www.theses.fr/1999PA05P200.
Pełny tekst źródłaBerthelot, Philippe. "Exploration endoscopique et instrumentation thérapeutique comme sources d'infection respiratoire nosocomiale". Saint-Etienne, 1993. http://www.theses.fr/1993STET6411.
Pełny tekst źródłaWolf-Lissorgue, Marie-France. "Enquête de prévalence instantanée concernant l'infection et la thérapeutique anti-infectieuse à l'hôpital Broussais". Paris 5, 1993. http://www.theses.fr/1993PA05P091.
Pełny tekst źródłaDelaunay, Isabelle. "La mucoviscidose : complications infectieuses pulmonaires : stratégies thérapeutiques médicale et chirurgicale, à propos de 4 observations d'adultes jeunes". Caen, 1990. http://www.theses.fr/1990CAEN3097.
Pełny tekst źródłaGauchet, Aurélie. "Les déterminants psychosociaux de l'observance thérapeutique chez les personnes infectées par le VIH : représentations et valeurs". Metz, 2005. http://docnum.univ-lorraine.fr/public/UPV-M/Theses/2005/Gauchet.Aurelie.LMZ0501_1.pdf.
Pełny tekst źródłaIn 1996 with the apparition of tritherapy, patients have to learn to live with their HIV and so with a chronic illness. Many publications have shown the importance of compliance (respect of medical prescription) with HIV patients. This study intends showing to which extent the compliance is influence by social and psychological variables significant. This research executed in 2002, gathered 127 HIV patients (aged from 18-65 years) which have filled up a questionnaire at the occasion of their quaterly consultation at the Metz Hospital (France). The subjects had to answer a French Compliance Scale (Tarquinio, Fisher Grégoire, 2000), the Illness Perception Questionnaire (IPQ, Weinman), the Belief Medical Questionnaire (BMQ, Horne), a French Value System Scale (Fischer), a treatment satisfaction scale and sociodemographic variables. We made multidimensional analyses (PCA : Principal Component Analysis ; Multiple Regression Analysis, and Structural Equation), in order to show the principal variables subjacent to scales. Results reveal that the social and psychological variables significant as patients'believes, their values, environmental factors and physician-patient relation, influence compliance. The principal variables which affect compliance are patients' believes about treatment, satisfaction about treatment, confidence beside the physician, social support, duration of treatment and illness, and truthful communication. The results of this study will give to the physicians the possibility to adjust their advices and the treatments in taking into account those social and psychological variables significant, in order to increase the compliance of HIV patients
Fontanet, Isabelle. "L'infection materno-fœtale : approche épidémiologique des unités de pathologie néonatale du Centre Hospitalier Régional de Bordeaux, approche thérapeutique (1992-1995)". Bordeaux 2, 1996. http://www.theses.fr/1996BOR23032.
Pełny tekst źródłaBonal-Saade, Catherine. "Infections congénitales à cytomégalovirus traitées par ganciclovir : à propos de deux observations". Montpellier 1, 1995. http://www.theses.fr/1995MON11067.
Pełny tekst źródłaZupanc, Kauss Tina. "Intérêt thérapeutique et formulation galénique des polyphénols dans le traitement des infections et inflammations". Bordeaux 2, 2007. http://www.theses.fr/2007BOR21501.
Pełny tekst źródłaImmune response can become a pathological process, leading to a joint matrix destruction in rheumatoid arthritis or to a chronic cachexia in African trypanosomosis. In both pathologies, new therapeutics are needed for a better patients care. Flavonols, non toxic vegetal compounds, could bring a therapeutic alternative in these diseases, but their anti-inflammatory and anti-parasitic effects should be proved and/or characterized. We evaluated therefore the therapeutic potential of two flavonols, quercetin and rutin, in view of their use in human medicine. The effects of non toxic doses of flavonols on macrophage inflammatory mediators' gene transcription and protein expression were studied. In vitro inhibition of TNFα? il1β and NO was also confirmed on rat adjuvant-induced arthritis model, showing a correlation between clinical signs of inflammation (clinical scores and cachexia) and serum inflammatory mediators. In addition, quercetin and rutin trypanocidal effects were demonstrated and the kinetics and dose-response relationship studied. Furthermore, the in vitro trypanocydal effect of vitamin C was highlighted. In vivo studies should confirm the effectiveness of these molecules in African trupanosomosis. A first galenic approach was also conducted in order to improve the bioavailability and consequent therapeutic effects of flavonols
Desrosiers, Vincent. "Nouvelle avenue thérapeutique pour traiter une infection par le VIH-1". Master's thesis, Université Laval, 2018. http://hdl.handle.net/20.500.11794/31388.
Pełny tekst źródłaMacrophages plays an important role in HIV-1 infection. These cells are suspected to act as a viral reservoir preventing complete virus eradication in infected individuals. Following a transcriptomic study, fifty genes were selected based upon their differential expression between non-infected, infected and bystander populations. One of those genes, coding for Gamma-Glutamyl Hydrolase (GGH), an enzyme involved in folate metabolism, was upregulated rapidly after HIV-1 infection before returning to a basal state. We propose that in monocyte-derived macrophages (MDM), a low folate concentration may play a protective role by limiting nucleotide availability for HIV-1 during the process of infection. We have developed an experimental model based on MDM identification productively infected with a R5 tropism HIV-1 molecular clone expressing all viral genes and a small membrane murine protein (Heat Stable Antigen; HSA). This virus was used to infect MDM transfected with small interfering RNAs (siRNA) or exposed to chemical inhibitors. The purpose of those experiments was to assess the effect of genetic downregulation of important folate proteins during HIV-1 infection. Between 3 and 18 days post-infection, percentage of productively infected cells was evaluated with flow cytometry or ELISA targeting the viral capsid protein p24. Downregulation of important enzymes involved in intracellular folate retention (e.g. GGH, FPGS and MTHFR) increased the number of cells productively infected with HIV-1. Also, Raltitrexed (RTX), a specific inhibitor of Tymidylate Synthase (TYMS), was able to inhibit viral replication when used before infection. Those results show that an interplay between HIV-1 and folate cycle may play a decisive role in MDM susceptibility to virus infection.
Książki na temat "Os – Infections – Thérapeutique"
Dariosecq, Jean-Michel. Infection VIH: Mémento thérapeutique 2003. Wyd. 6. Rueil-Malmaison: Doin, 2003.
Znajdź pełny tekst źródłaMalago, Joshua J. Probiotic Bacteria and Enteric Infections: Cytoprotection by Probiotic Bacteria. Dordrecht: Springer Science+Business Media B.V., 2011.
Znajdź pełny tekst źródłaPowderly, William G. Manual of HIV therapeutics. Wyd. 2. Philadelphia: Lippincott Williams & Wilkins, 2001.
Znajdź pełny tekst źródłaMoss, Adrian. HIV and AIDS: Management by the primary care team. Oxford: Oxford University Press, 1992.
Znajdź pełny tekst źródłaCatalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.
Znajdź pełny tekst źródłaCatalán, José. Psychological medicine of HIV infection. Oxford: Oxford University Press, 1995.
Znajdź pełny tekst źródłaMichael, Moore. Herbs for the urinary tract: Herbal relief for kidney stones, bladder infections, and other problems of the urinary tract. New Canaan, Conn: Keats Publishing, 1998.
Znajdź pełny tekst źródłaInternational Conference on Endotoxins Amsterdam (3rd 1990). Bacterial endotoxins: Cytokine mediators and new therapies for sepsis : proceedings of the Third International Conference on Endotoxins, held in Amsterdam, the Netherlands, June 7-8, 1990. Redaktorzy Sturk Auguste, International Endotoxin Society, European Shock Society i European Conference on Intensive Care Medicine (5th : 1990 : Amsterdam, Netherlands). New York: Wiley-Liss, 1991.
Znajdź pełny tekst źródłaKaiser, Jon D. Healing HIV: How to rebuild your immune system. Mill Valley, Calif: HealthFirst Press, 1999.
Znajdź pełny tekst źródłaFinley, Bryce. Echinacea: How to grow, harvest, and use this amazing flower to fight colds, flu, and infection by boosting your immune system. Christina Lake, B.C., Canada: B. Finley, 1994.
Znajdź pełny tekst źródłaCzęści książek na temat "Os – Infections – Thérapeutique"
Klastersky, J., i M. Aoun. "Prévention et traitement des infections". W Thérapeutique du cancer, 151–65. Paris: Springer Paris, 2011. http://dx.doi.org/10.1007/978-2-8178-0021-9_10.
Pełny tekst źródłaNavas, Dominique, Jean-François Huon i Stéphane Ploteau. "Traitement des infections gynécologiques". W Pharmacie Clinique et Thérapeutique, 815–24. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00045-1.
Pełny tekst źródłaKaiser, Jean-Daniel, Joël Leroy i Samuel Limat. "Traitement des infections osseuses". W Pharmacie Clinique et Thérapeutique, 825–32. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00046-3.
Pełny tekst źródłaKaiser, Jean-Daniel, Joël Leroy i Samuel Limat. "Traitement des infections digestives". W Pharmacie Clinique et Thérapeutique, 843–52. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00048-7.
Pełny tekst źródłaFerreira, Ema, i Natacha Chaumard. "Traitement des infections gynécologiques". W Pharmacie clinique et thérapeutique, 993–1003. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50049-1.
Pełny tekst źródłaSinglas, Éric, i Nicole Desplaces. "Traitement des infections osseuses". W Pharmacie clinique et thérapeutique, 1005–14. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50050-8.
Pełny tekst źródłaSteinmetz, Jean-Philippe, Marie-Odile Decroix†, Jean-Philippe Steinmetz i Matthieu Roustit. "Traitement des infections digestives". W Pharmacie clinique et thérapeutique, 1029–40. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50052-1.
Pełny tekst źródłaBarrail-Tran, Aurélie. "Traitement des infections urinaires bactériennes". W Pharmacie Clinique et Thérapeutique, 791–800. Elsevier, 2018. http://dx.doi.org/10.1016/b978-2-294-75077-9.00043-8.
Pełny tekst źródłaRaignoux, Cécile, Robert Farinotti, Robert Farinotti, François Gimenez† i Anne-Claude Crémieux. "Traitement des infections urinaires bactériennes". W Pharmacie clinique et thérapeutique, 959–69. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50046-6.
Pełny tekst źródłaArmoiry, Xavier, Xavier Dode, Gilles Aulagner, François Gimenez†, Bruno Crestani i Sophie Raymond. "Traitement des infections respiratoires basses bactériennes". W Pharmacie clinique et thérapeutique, 971–80. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-06234-6.50047-8.
Pełny tekst źródłaStreszczenia konferencji na temat "Os – Infections – Thérapeutique"
Oujdad, S., S. Zafad, H. El Attar i I. Ben Yahya. "Histiocytose langerhansienne de l’adulte : à propos d’un cas". W 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603013.
Pełny tekst źródła